Trials / Conditions / Mild Autonomous Cortisol Secretion (MACS)
Mild Autonomous Cortisol Secretion (MACS)
6 registered clinical trials studyying Mild Autonomous Cortisol Secretion (MACS) — 5 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS NCT07138274 | Mayo Clinic | Phase 2 |
| Recruiting | IMPACT-MACS: Adrenalectomy vs Semaglutide for Metabolic Outcomes in Mild Autonomous Cortisol Secretion NCT07361874 | University of Texas Southwestern Medical Center | N/A |
| Recruiting | Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS) NCT07247058 | Johns Hopkins University | Phase 4 |
| Recruiting | Metyrapone Versus Osilodrostat in Patients With Metabolic Autonomous Cortisol Secretion (MACS) NCT07268222 | Laikο General Hospital, Athens | Phase 4 |
| Recruiting | Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma NCT06344143 | The Cleveland Clinic | — |
| Active Not Recruiting | Metyrapone for Mild Autonomous Cortisol Secretion (MACS) NCT06106295 | Mayo Clinic | Phase 2 |